Agenus AGEN
NASDAQ AGEN
$8.29 +0.05 (+0.61%)
As of: Sep 4, 2026 · 2:25 PM EDT

Agenus (AGEN) Change in Receivables (2010 - 2026)

Agenus (AGEN) posted quarterly Change in Receivables of $4.7 million for Q1 2026, up 4480.56% year-over-year from $103284.4 in Q1 2025, and up 181.77% quarter-over-quarter from $1.7 million in Q4 2025.

Analysis

Agenus (AGEN) Change in Receivables (2010 - 2026) Analysis & Trends

Agenus' Change in Receivables history runs 17 years deep, the most recent figure standing at $4.7 million for Q1 2026.

  • In Q1 2026, Change in Receivables rose 4480.56% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $6.6 million (up 6016.22% YoY), while the FY2025 annual figure was $1.7 million, up 106.82% from the prior year.
  • Change in Receivables for Q1 2026 stood at $4.7 million, up from $1.7 million in the prior quarter.
  • The five-year high for Change in Receivables was $24.8 million in Q4 2023, with the low at -$25.3 million in Q1 2024.
  • The 5-year median for Change in Receivables is -$108000.0 (2025), against an average of $262000.0.
  • The sharpest annual moves came in 2024 and 2026: Change in Receivables tumbled 1862.9% in 2024, then jumped 4480.56% in 2026.
  • Agenus' Change in Receivables stood at -$7.2 million in 2022, then soared by 443.97% to $24.8 million in 2023, then plunged by 98.91% to $269000.0 in 2024, then surged by 524.16% to $1.7 million in 2025, then surged by 181.77% to $4.7 million in 2026.
  • Business Quant data shows AGEN's Change in Receivables at $4.7 million in Q1 2026, $1.7 million in Q4 2025, and -$183000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -53.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 117.58 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 31.60 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 37.16 Mn
10 Agenus 342.69 Mn 342.69 Mn 34.52 Mn 8.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.16 Mn
Mar 31, 2026 4.73 Mn
Dec 31, 2025 1.68 Mn
Sep 30, 2025 -183,000.00
Jun 30, 2025 340,000.00
Mar 31, 2025 -108,000.00
Dec 31, 2024 269,000.00
Sep 30, 2024 -492,000.00
Jun 30, 2024 220,000.00
Mar 31, 2024 -25.34 Mn
Dec 31, 2023 24.77 Mn
Sep 30, 2023 -287,000.00
Jun 30, 2023 270,000.00
Mar 31, 2023 -1.29 Mn
Dec 31, 2022 -7.20 Mn
Sep 30, 2022 -10.05 Mn
Jun 30, 2022 17.27 Mn
Mar 31, 2022 -135,000.00
Dec 31, 2021 -20.20 Mn
Sep 30, 2021 20.33 Mn